SANTA CLARA, Calif.--In its latest quarterly earnings report, Affymetrix noted significant progress in each of its three business areas: gene expression profiling, polymorphism analysis, and disease management. The company also unveiled a new bioinformatics product, the GeneChip Expression Data Mining Tool, during the quarter ended September 30.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.